6 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic(PK/PD) Profile of ACT500 in Metabolic Dysfunction-Associated Steatotic Liver Disease(MASLD)metabolic dysfunction-associated steatohepatitisNot yet recruitingPhase 12026-09-14NCT07462455
A Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients With nAMDeye disorder, macular degeneration, retinal degeneration, retinal disorderRecruitingNot stated2026-09-01NCT06346600
A Phase Ib/IIa Study of INT-210 Capsules in Participants With Active Ulcerative ColitisDigestive System Diseases, colitis, colonic disorder, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder, ulcerative colitisRecruitingPhase 1 / Phase 22026-07-09NCT07692165
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 MutationNeoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorderRecruitingPhase 32026-06-22NCT05696626
The Efficacy and Safety of Inpegsomatropin Injection in Children With Idiopathic Short StatureIdiopathic Short StatureRecruitingPhase 32026-03-11NCT06927310
The Efficacy and Safety of Efsubaglutide Alfa Injection in Overweight and Obese Subjects (ENLIGHT)Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutritionActive, not recruitingPhase 2 / Phase 32026-01-30NCT06921486